Loading stock data…
QNRX
$6.21-0.27 (-4.17%)
Market ClosedLast close May 1
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Quoin Pharmaceuticals, Ltd. in the Healthcare sector is trading at $6.21. The stock is currently near its 52-week low of $5.20, remaining 36.6% below its 200-day moving average. Technical signals show neutral RSI of 55 and bullish MACD crossover, explaining why QNRX maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 55) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$6.21
Potential Upside
5%
Whystock Fair Value$6.52
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Mean target$29.67+377.7%
Range$14.00 – $40.00
Fundamentals
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.35M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.82
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-120.46%
Volume
Today's trading volume
9,456
Recent News
Quoin Pharmaceuticals Insider Ups Holding By 1,515,200% During Year
Looking at Quoin Pharmaceuticals, Ltd.'s ( NASDAQ:QNRX ) insider transactions over the last year, we can see that...
Top Midday Gainers
Quoin Pharmaceuticals (QNRX) shares soared 126% amid heavy trading intraday after the company said F
Quoin Pharmaceuticals Shares Jump After Announcing $104.5 Million Private Placement
Quoin Pharmaceuticals (QNRX) shares jumped nearly 170% in recent Friday trading after the company sa
Quoin Pharmaceuticals Says US FDA Clears Second Netherton Syndrome Pivotal Study
Quoin Pharmaceuticals (QNRX) said Thursday that it has received US Food and Drug Administration clea